Projects as Principal Investigator
Showing records 1 - 13 (of 13)
Principal Investigator
Title
Organization
Status
ID
Prünte, Christian
The safety, tolerability and pharmacokinetics of a single intravenous infusion of 10, 40 and 80 ?g/kg XG-102 administered to healthy male volunteers in a randomized, double blind, placebo controlled, dose escalating Phase I study, Sponsor protocol identifying number: SDD-1002-024 CRO protocol identifying number: BCRU560-1 Ophthalmologie USB
Completed
1201933
Prünte, Christian
Single Dose Study of the Safety and Efficacy of AGN-150998 in Patients with Exudatice Age-related Macular Degeneration" Ophthalmologie USB
Completed
1201932
Prünte, Christian
A 2 year randomized, sigle-masked, multicenter, controlled phase IIIb trial assessing the Efficacy and safety of 0.5mg ranibizumab in two "treat and extend" Treatment algorithms vs. 0.5mg ranibizumab as needed in patients with macular edema and visual Impairment secondary to Diabetes mellitus ("the Study"), Ranibizumab ("the Study Drug") - CRFB002D2304 Ophthalmologie USB
Completed
1201931
Prünte, Christian
Time course of activity signs at High Resolution OCT during OCT-guided high frequency intravitreal ranibizumab treatment in choroidal neovascularization due to age related macular degeneration Ophthalmologie USB
Completed
1201929
Prünte, Christian
A cross sectional study assessing the prevalence of different stages of diabetic retinopathy and diabetic macular edema among type 1 diabetic patients treated with long-term intensified insulin therapy aiming near-normal blood glucose levels Ophthalmologie USB
Completed
1201927
Prünte, Christian
Accelerated Intravitreal Ranibizumab Injection Frequency in Poor Responders (AIR) Ophthalmologie USB
Completed
1201925
Prünte, Christian
A Dose-Escalation Study of AL-39324 Suspension versus Lucentis® for the Treatment of Exudative Age-Related Macular Degeneration Ophthalmologie USB
Completed
1201919
Prünte, Christian
A Randomized, Double-blind, Placebo-controlled, Phase 2 Study of the Effects of XOMA 052 on Insulin Production in Subjects with Well-controlled Type 1 Diabetes, X052076 Ophthalmologie USB
Completed
1201918
Prünte, Christian
Vergleich der klinischen Sicherheit und Wirksamkeit von NEVANAC® 0,1% mit dem Vehikel nach Kataraktoperation bei Patienten mit diabetischer Retinopathie. Ophthalmologie USB
Completed
1201916
Prünte, Christian
A 12-Month, Multicenter, 2-Stage (Open Label, Dose-Escalation, Followed by Masked, Randomized) Sigle Dose Study of the Safety and Effiacy of AGN-208397 in Patients with Macular Edema (ME) Associated with Retinal Vein Occlusion (RVO) Ophthalmologie USB
Completed
1201915
Prünte, Christian
The Safety and Efficacy of AL-8309B Ophtalmic Solution fot the Treatment of Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) Ophthalmologie USB
Completed
1201913
Prünte, Christian
SD-OCT-guided intravitreal ranibizumab treatment in choroidal neovascularization due to myopia Ophthalmologie USB
Completed
1201912
Prünte, Christian
Implementing elements of the Chronic Care Model in the care for neovascular age-related macular degeneration (wet AMD). Is it superior to usual care? A randomised controlled trial. Ophthalmologie USB
Completed
1201876
Showing records 1 - 13 (of 13)
MCSS v5.8 PRO. 0.005 sec, queries - 0.000 sec
©Universität Basel | Impressum
|
25/04/2024
Research Database / FORSCHUNGSDATENBANK
